Historical record - last NADAC effective date: 2/23/2022
Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.0735 per EA under NDC 69238110305. Its NADAC has been published 356 times since May 27, 2015.
FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238110305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/23/2022
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078329FDA Approved
2/5/2009
TE Code
AB
On Market Since
4/1/2014
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 356 times since May 27, 2015, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0735 per EA |
|---|---|
| All-time high | $0.0933 (Mar 11, 2020) |
| All-time low | $0.0483 (Dec 20, 2017) |
| Median price | $0.0639 |
| Average price | $0.0675 |
| Largest weekly change | +16.3% (Aug 21, 2019) |
| Weeks tracked | 356 |
| Tracking since | May 27, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-3.9%
All
+9.7%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.0735 per EA (NDC 69238110305), effective Mar 16, 2022.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has risen 9.7%. It has been tracked across 356 weekly CMS publications since May 27, 2015.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since May 27, 2015, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0483 (Dec 20, 2017) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0639 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 23% below IBUPROFEN 800 MG TABLET.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 69238110305) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.